Brain amine concentrations after monoamine oxidase inhibitor administration

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Monoamine oxidase inhibitors (MAOIs) are used to treat depression.
• Understanding their effects on neurotransmitter concentrations is crucial for clinical application.

Purpose of the Study:

• To quantify post mortem brain concentrations of 5-hydroxytryptamine (5HT), noradrenaline, and dopamine.
• To compare the effects of isocarboxazid, clorgyline, and tranylcypromine on these neurotransmitters.

Main Methods:

• Post mortem analysis of brain tissue (brain stem, hypothalamus, caudate nucleus).
• Measurement of neurotransmitter concentrations in 33 patients treated with MAOIs and 11 controls.
• Comparison of drug effects on dopamine, 5HT, and noradrenaline levels.

Main Results:

• All three MAOIs (isocarboxazid, clorgyline, tranylcypromine) significantly increased 5HT and noradrenaline concentrations.
• Tranylcypromine showed a greater effect on dopamine in the caudate nucleus and hypothalamus compared to the other MAOIs.
• Chlorpromazine did not reduce amine concentrations at the doses used.
• Parkinson's patients exhibited low dopamine levels despite MAOI treatment.

Conclusions:

• MAOIs effectively increase brain 5HT and noradrenaline, with varying effects on dopamine.
• Individual patient responses to MAOIs can differ, with some showing minimal amine level increases.
• Further research is needed to understand MAOI efficacy in conditions like Parkinson's syndrome.